Toutes les études
RecrutementPhase IVInterventionnel

DEsogestrel for Bleeding on the Implant (DEBI)

This study, called DEBI, aims to find a better way to help people who experience frustrating bleeding while using the contraceptive implant. The implant is highly effective at preventing pregnancy, but many people have it removed early due to period problems. We're comparing desogestrel, a hormone-only tablet, with the combined oral contraceptive pill (COCP), which contains two hormones. Desogestrel might be safer, cheaper, and easier to access for some. The research wants to see if desogestrel is just as good as the COCP in stopping problem bleeding within 90 days. If it is, it could provide a new, improved treatment option for many implant users.

En un coup d'œil

Statut
Recrutement
Phase
Phase IV
Sponsor
Université de Nottingham
Objectif d'inscription
690
Démarrer
30 Sep 2025
Achèvement estimé
30 Apr 2027

De quoi parle cette étude ?

The contraceptive implant is a small rod placed under the skin of your arm that's incredibly good at preventing pregnancy – more than 99% effective. However, a common issue for some people using it is bothersome and unpredictable bleeding or spotting. This can be so frustrating that about a quarter of users decide to have their implant removed early, which can sometimes lead to unplanned pregnancies.

Currently, doctors often suggest taking the combined oral contraceptive pill (COCP) to try and sort out this bleeding. Our study is looking at another treatment option: desogestrel. This is a "mini-pill" that only contains one type of hormone, unlike the COCP which has two. Desogestrel might be a more suitable option for some people, especially those who can't take the combined pill or prefer not to. It's also potentially safer and more affordable, and doesn't require the regular blood pressure and weight checks needed for the combined pill.

The main goal of this research is to see if desogestrel is just as good as the combined pill at reducing problem bleeding within 90 days. If it is, it could mean a simpler, safer, and easier-to-get treatment for people struggling with bleeding while on the implant. This could help more people continue using this very effective form of contraception.

Points clés

  • Exploring new ways to manage problematic bleeding with the contraceptive implant.
  • Comparing desogestrel (mini-pill) with the combined pill (COCP).
  • Aims to find a safer, simpler, and more accessible treatment.
  • Participation involves taking daily tablets and keeping a bleeding diary for 90 days.
  • No extra clinic visits needed; designed to be easy for participants.

Qui peut être éligible ?

This study is looking for around 690 people who are currently using the contraceptive implant and are experiencing bothersome bleeding. You need to be between 16 and 45 years old and have had your implant in for at least 3 months but no longer than 24 months.

"Problem bleeding" simply means any bleeding (like spotting or heavy bleeding) that you find disruptive or concerning. You'll need to be willing to keep a daily diary of your bleeding throughout the study.

There are some reasons why you might not be able to join, such as if you recently used certain medications or hormones that affect your period, have had certain types of surgery, or have specific medical conditions. The study team will check all these details carefully to make sure the study is right for you.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you between 16 and 45 years old?
  2. Do you currently have a contraceptive implant?
  3. Has your implant been in for at least 3 months, but no more than 2 years?
  4. Are you experiencing bleeding with your implant that you find problematic?
  5. Are you willing to keep a daily bleeding diary?
  6. Can you provide your informed consent to participate?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you join the study, you'll be randomly given either desogestrel tablets or combined oral contraceptive pill tablets to take. You'll take these tablets daily for 90 days.

The main thing you'll need to do is keep a simple daily diary about your bleeding throughout this period. The study has been designed to reduce the time commitment for you, so these daily diaries and a few short questions about taking your medication will be the main task. There aren't any extra doctor's appointments or follow-up visits needed for the study beyond your usual care. The total active participation in terms of taking medication and recording information will be mainly for the 90 days.

Risques et avantages potentiels

Taking part in this study could help us find a better, simpler treatment for implant-related bleeding, potentially benefiting many people in the future. You will receive either desogestrel or the combined pill, which are both established medications for contraception. However, in this study, they are being used specifically to manage implant-related bleeding. Both medications have known side effects, which will be fully explained to you in detail by the study doctor and in the patient information sheets. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (25)

  • Trust des hôpitaux universitaires de Nottingham NHS
    Ville uniquement
    Nottingham, England
  • Leeds Community Healthcare NHS Trust
    Approximatif
    Leeds, England
  • Cambridgeshire Community Services NHS Trust
    Ville uniquement
    St. Ives, England
  • University Hospitals Sussex NHS Foundation Trust
    Ville uniquement
    Worthing, England
  • Hampshire and Isle of Wight Healthcare NHS Foundation Trust
    Ville uniquement
    Southampton, England
  • University of Nottingham Health Service
    Non vérifié
    Nottingham, England
  • Kingston and Richmond NHS Foundation Trust
    Non vérifié
    Kingston upon Thames, England
  • Northamptonshire Healthcare NHS Foundation Trust
    Non vérifié
    Kettering, England
  • Fondation des Hôpitaux Universitaires de Birmingham NHS
    Non vérifié
    Birmingham, Angleterre
  • Liverpool University Hospitals NHS Foundation Trust
    Non vérifié
    Liverpool, England
  • London North West University Healthcare NHS Trust
    Non vérifié
    Harrow, England
  • The Royal Wolverhampton NHS Trust
    Non vérifié
    Wolverhampton, England

Questions fréquentes

What is the contraceptive implant?

It's a small, flexible rod placed under the skin of your arm that releases hormones to prevent pregnancy for up to 3 years. It's very effective.

What kind of bleeding is considered 'problem bleeding'?

It's any bleeding, like spotting or heavy periods, that you personally find frustrating or bothersome while using your implant.

Saurai-je quel traitement je reçois ?

The study is 'blinded', meaning you won't know if you're taking desogestrel or the combined pill until the study is over. This helps ensure fair results.

Do I have to visit the clinic often?

No, there are no extra follow-up visits specifically for the study, beyond any appointments you'd usually have with your doctor.

Que se passe-t-il si je change d'avis concernant ma participation ?

You are free to leave the study at any point, and you don't need a reason. Your usual medical care will not be affected.

Comment en savoir plus

Jo Brooks

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "DEsogestrel for Bleeding on the Implant (DEBI)… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.